Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

A Clinician View and Experience of Proteomic Studies in the Light of Lung Cancer in Japanese Healthcare

In English

Författare

  • Harubumi Kato
  • Toshihide Nishimura
  • Takashi Hirano
  • Masaharu Nomura
  • Hiromasa Tojo
  • Kiyonaga Fujii
  • Takeshi Kawamura
  • Sayaka Mikami
  • Makoto Kihara
  • Yasuhiko Bando
  • Masahiro Tsuboi
  • Norihiko Ikeda
  • György Marko-Varga
Visa allt

Summary, in English

In Japan, rising costs have impacted the framework of maintaining an efficient and effective healthcare system. Today, urgent implementation of programs to address this need have led to a rebuilding of the entire approach of medical evaluation and clinical care. Recent developments in clinical proteomics based on mass spectrometry (MS) for identifying, sequencing, and quantifying disease-relevant protein biomarkers is a promising means for optimal drug prescription using biomarker diagnosis. We illustrate in this report our experience with lung cancer cases with various drug therapies evaluated with proteomics studies.

Publiceringsår

2011

Språk

Engelska

Sidor

51-57

Publikation/Tidskrift/Serie

Journal of Proteome Research

Volym

10

Issue

1

Dokumenttyp

Artikel i tidskrift

Förlag

The American Chemical Society (ACS)

Ämne

  • Analytical Chemistry

Nyckelord

  • lung cancer
  • diagnosis and treatment
  • proteomic study
  • healthcare

Status

Published

ISBN/ISSN/Övrigt

  • ISSN: 1535-3893